Always happy to hear your feedback.
©2021 Impeka WordPress Theme

Our Services

We generate value to our clients thanks to our team combining strategic advice expertise with robust technical capabilities.

Global & Local

Clever-Access can operate at the global level, providing strategic advice on the market access roadmap or coordinating a product launch for example, or at the local level, developing local reimbursement dossiers for instance.

pexels-photo-3646172@0.1x

Identify, Synthesize, Implement & Generate

We support clients in identifying gaps to fill, synthesize what is already available, implement new solutions & generate new evidence.

Methodology & Strategy

At Clever-Access, our passion for methodology and our internal strategic experience ensures success for the full range of solutions in both Market Access and HEOR.

Evidence Review & Synthesis

Evidence reviews should be considered as the foundation of informed decision making.

Whether your studies are integrated by commercial teams in strategic decisions or required by HTA agencies and payers, whether they use a systematic process, or a more pragmatic approach, reviews are an appropriate approach for understanding and synthesis of available literature.

Our multidisciplinary team will ensure flexibility, transparency, clarity, comprehensiveness, and highest quality.

Our solutions:

  • Systematic Literature Reviews (SLRs)
  • Targeted Literature Reviews (TLRs)
  • Reviews Updates
  • Writing & Submission of Publications

Health Economic Modelling

Health economic simulations may support your internal decision making at early stage, your reimbursement dossiers and payer negotiations.

Whether they aim to document local reimbursement dossiers or payer negotiations, or to inform your product value, our multidisciplinary team will ensure flexibility, transparency, clarity, comprehensiveness, and highest quality.

Our solutions:

  • Cost-effectiveness & Budget Impact Modelling
  • Epidemiologic Modelling
  • Cost Calculator
  • Model Adaptation to Local Requirements
  • Model Quality Checks

Strategic Advice for Pricing and Market Access

Our solutions:

  • Pricing and Market Access Landscape Analysis including Primary and Secondary
    Research
  • Early Dialogues with Payers and Regulators
  • Pricing and Market Access Strategy and RoadMap, including Early Strategic
    Positioning, Assessment of Risks and Opportunities
  • Market Assessment and Evidence Generation Plan
  • Market Entry Agreements Strategy
  • Ad-hoc Consulting

Value Communication

Value communication is the final vehicle of all the extensive work performed to demonstrate the value of your product. An impactful but concise value story is critical to convey your message to external decision makers. The challenge is to find the right balance between all value building blocks so your story stays clear.

Together with our network of selected international, external, and independent experts, working with us for many years, our market access team can support our clients from early stage to post launch.

Our solutions:

  • Value Messages / Value Proposition, Development and Testing
  • Global / Core Value Dossier

HTA submissions

Our team has experience in local HTA submissions, in several countries around the world, including France, the UK, Canada, US and Japan.

We can handle it all, or collaborate with local partners when necessary.

Our solutions:

  • Early consultations with HTA agencies or joint consultations HTA / EMA
  • Local dossiers development and post-submission support
  • Local dossier review and critical analysis
  • Economic argument dossiers
  • Mock HTA panels

Data Analytics

With the exponential availability of data, along with the requirements of health authorities on data transparency and evidence, it is crucial to identify what data is needed to build the necessary and the correct evidence demonstrating the product’s value.

Our experienced team of statisticians has conducted 100+ post-hoc analyses of clinical trial data, pooled analyses of multiple clinical trials, real-world evidence, in-depth analyses of PRO data, data mining, and “Big Data” analyses for hypothesis generation.

Our solutions:

  • Post-hoc Analyses
  • Indirect Treatment Comparisons (ITC, NMA, MAIC etc)
  • Real-World Evidence Counselling
  • Patients Reported Outcomes
  • Statistical Analyses Plan and Results